A test developed by Quest Diagnostics (Madison, Wisconsin) could give greater insight into the likelihood of female patients developing cervical cancer. Late last week the company reported the availability of a the test, which is designed to help physicians identify women who are at increased risk of developing malignancy, unless treated, after receiving unclear results for cervical cancer risk from standard screening tests. Read More
